3 years ago

Antithrombotic Therapies in Digit Replantation with Papaverine Administration: A Prospective, Observational Study

Antithrombotic Therapies in Digit Replantation with Papaverine Administration:  A Prospective, Observational Study
Zheng, Xianyou, Zhu, Xiaozhong, Zhu, Hongyi
Background: The primary objective of this study was to investigate whether the application of antithrombotic therapies affects the success rate of digit replantation. Methods: A total 477 digits of 319 patients who received dextran with low-molecular-weight heparin, dextran with prostaglandin E1, or no antithrombotic therapy after replantation of complete amputated digits from January 1, 2012, to January 1, 2016, were included in this study. Papaverine was given by intramuscular injection to all patients at a dosage of 90 mg/day postoperatively. Results: There was no significant difference in any of the potential risk factors, including age, smoking, Tamai level of amputation, causes of injury, and warm ischemia time among groups. The survival rates of digits from patients who received dextran with low-molecular-weight heparin, dextran with prostaglandin E1, or no antithrombotic therapy were not significantly different. Conclusion: Antithrombotic therapies showed no significant benefit for digit replantation in patients receiving papaverine. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
You might also like
Never Miss Important Research

Researcher is an app designed by academics, for academics. Create a personalised feed in two minutes.
Choose from over 15,000 academics journals covering ten research areas then let Researcher deliver you papers tailored to your interests each day.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.